- Home
- REVB vs STSS Comparison
REVB vs STSS Comparison
Compare REVB & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVB
- STSS
- Stock Information
- Founded
- REVB 2020
- STSS 2017
- Country
- REVB United States
- STSS United States
- Employees
- REVB N/A
- STSS N/A
- Industry
- REVB Biotechnology: Pharmaceutical Preparations
- STSS Medical/Dental Instruments
- Sector
- REVB Health Care
- STSS Health Care
- Exchange
- REVB Nasdaq
- STSS Nasdaq
- Market Cap
- REVB 4.4M
- STSS 5.1M
- IPO Year
- REVB N/A
- STSS 2022
- Fundamental
- Price
- REVB $2.87
- STSS $10.74
- Analyst Decision
- REVB
- STSS
- Analyst Count
- REVB 0
- STSS 0
- Target Price
- REVB N/A
- STSS N/A
- AVG Volume (30 Days)
- REVB 87.7K
- STSS 3.1M
- Earning Date
- REVB 11-07-2025
- STSS 08-13-2025
- Dividend Yield
- REVB N/A
- STSS N/A
- EPS Growth
- REVB N/A
- STSS N/A
- EPS
- REVB N/A
- STSS N/A
- Revenue
- REVB N/A
- STSS $222,722.00
- Revenue This Year
- REVB N/A
- STSS N/A
- Revenue Next Year
- REVB N/A
- STSS N/A
- P/E Ratio
- REVB N/A
- STSS N/A
- Revenue Growth
- REVB N/A
- STSS N/A
- 52 Week Low
- REVB $2.11
- STSS $3.36
- 52 Week High
- REVB $60.48
- STSS $2,145.00
- Technical
- Relative Strength Index (RSI)
- REVB 56.54
- STSS 57.63
- Support Level
- REVB $2.65
- STSS $8.90
- Resistance Level
- REVB $2.88
- STSS $13.50
- Average True Range (ATR)
- REVB 0.19
- STSS 2.42
- MACD
- REVB 0.03
- STSS 0.24
- Stochastic Oscillator
- REVB 88.00
- STSS 45.29
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.